Initial report of decreased SARS-CoV-2 viral load after inoculation with the BNT162b2 vaccine
- PMID: 33782619
- DOI: 10.1038/s41591-021-01316-7
Initial report of decreased SARS-CoV-2 viral load after inoculation with the BNT162b2 vaccine
Abstract
Beyond their substantial protection of individual vaccinees, coronavirus disease 2019 (COVID-19) vaccines might reduce viral load in breakthrough infection and thereby further suppress onward transmission. In this analysis of a real-world dataset of positive severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) test results after inoculation with the BNT162b2 messenger RNA vaccine, we found that the viral load was substantially reduced for infections occurring 12-37 d after the first dose of vaccine. These reduced viral loads hint at a potentially lower infectiousness, further contributing to vaccine effect on virus spread.
Similar articles
-
Viral loads of Delta-variant SARS-CoV-2 breakthrough infections after vaccination and booster with BNT162b2.Nat Med. 2021 Dec;27(12):2108-2110. doi: 10.1038/s41591-021-01575-4. Epub 2021 Nov 2. Nat Med. 2021. PMID: 34728830
-
Symptomatic SARS-CoV-2 infections after full schedule BNT162b2 vaccination in seropositive healthcare workers: a case series from a single institution.Emerg Microbes Infect. 2021 Dec;10(1):1254-1256. doi: 10.1080/22221751.2021.1942230. Emerg Microbes Infect. 2021. PMID: 34110974 Free PMC article.
-
Impaired Humoral Response in Renal Transplant Recipients to SARS-CoV-2 Vaccination with BNT162b2 (Pfizer-BioNTech).Viruses. 2021 Apr 25;13(5):756. doi: 10.3390/v13050756. Viruses. 2021. PMID: 33923063 Free PMC article.
-
Potential effects of vaccinations on the prevention of COVID-19: rationale, clinical evidence, risks, and public health considerations.Expert Rev Vaccines. 2020 Oct;19(10):919-936. doi: 10.1080/14760584.2020.1825951. Epub 2020 Oct 6. Expert Rev Vaccines. 2020. PMID: 32940090 Review.
-
Efforts towards a COVID-19 vaccine.Environ Microbiol. 2020 Oct;22(10):4071-4084. doi: 10.1111/1462-2920.15225. Epub 2020 Sep 28. Environ Microbiol. 2020. PMID: 32893468 Review.
Cited by
-
Inactivated Poliovirus Vaccine Booster Reduces the Likelihood of COVID-19 Outcomes in Individuals Primed with Oral Poliovirus Vaccination.Vaccines (Basel). 2024 Feb 20;12(3):219. doi: 10.3390/vaccines12030219. Vaccines (Basel). 2024. PMID: 38543853 Free PMC article.
-
Efficacy of the COVID-19 vaccination in patients with asymptomatic or mild illness during the Omicron epidemic in Guangzhou: a multi-centre retrospective cohort study.Ann Med. 2024 Dec;56(1):2307504. doi: 10.1080/07853890.2024.2307504. Epub 2024 Mar 11. Ann Med. 2024. PMID: 38465636 Free PMC article.
-
Vaccination protects against acute respiratory distress syndrome (ARDS) in hospitalized patients with COVID-19.Clin Exp Med. 2024 Jan 27;24(1):21. doi: 10.1007/s10238-023-01293-w. Clin Exp Med. 2024. PMID: 38280024 Free PMC article.
-
Humoral Immune Responses following COVID-19 Vaccinations among Adults in Tanzania.Vaccines (Basel). 2023 Dec 23;12(1):22. doi: 10.3390/vaccines12010022. Vaccines (Basel). 2023. PMID: 38250835 Free PMC article.
-
Public health-focused use of COVID-19 rapid antigen and PCR tests.Sci Rep. 2024 Jan 16;14(1):1430. doi: 10.1038/s41598-023-50533-2. Sci Rep. 2024. PMID: 38228695 Free PMC article.
References
-
- Polack, F. P. et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N. Engl. J. Med. 383, 2603–2615 (2020). - DOI
-
- Chodcik, G. et al. The effectiveness of the first dose of BNT162b2 vaccine in reducing SARS-CoV-2 infection 13–24 days after immunization: real-world evidence. Preprint at medRxiv https://doi.org/10.1101/2021.01.27.21250612 (2021).
-
- Gallagher, M. E. et al. Indirect benefits are a crucial consideration when evaluating SARS-CoV-2 vaccine candidates. Nat. Med. 27, 4–5 (2021). - DOI
-
- Rubin, E. J. & Longo, D. L. SARS-CoV-2 vaccination: an ounce (actually, much less) of prevention. N. Engl. J. Med. 383, 2677–2678 (2020). - DOI
-
- Pollard, A. J. & Bijker, E. M. A guide to vaccinology: from basic principles to new developments. Nat. Rev. Immunol. 21, 129 (2021).
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous